DBV Technologies(DBVT) - 2023 Q4 - Annual Results

Exhibit 99.1 Anticipated 2024 Events Press Release Montrouge, France, March 7, 2024 DBV Technologies Reports Full Year 2023 Financial Results and Business Update DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today reported financial results for the full year 2023. The audit procedures have been substantially comp ...